| |
Latest 10 SEC filings (by transaction date) for BLUE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 4/24 | Obenshain Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -6,095 | $1.53 |
Mar 5/24 | Mar 4/24 | Klima Thomas J | Direct Ownership | Common Stock | S - Open market or private sale | -4,573 | $1.53 |
Mar 5/24 | Mar 1/24 | Colvin Richard A | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Colvin Richard A | Direct Ownership | Common Stock | S - Open market or private sale | -6,770 | $1.53 |
Mar 5/24 | Mar 1/24 | Vittiglio Joseph | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Krawtschuk Christopher | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Obenshain Andrew | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 650,000 | |
Mar 5/24 | Mar 1/24 | Klima Thomas J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Feb 6/24 | Feb 5/24 | Klima Thomas J | Direct Ownership | Common Stock | S - Open market or private sale | -2,714 | $0.903 |
Feb 6/24 | Feb 5/24 | Vittiglio Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -5,217 | $0.903 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BLUE within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 1/24 | Colvin Richard A | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Colvin Richard A | Direct Ownership | Common Stock | S - Open market or private sale | -6,770 | $1.53 |
Mar 5/24 | Mar 1/24 | Vittiglio Joseph | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Krawtschuk Christopher | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 1/24 | Obenshain Andrew | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 650,000 | |
Mar 5/24 | Mar 4/24 | Obenshain Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -6,095 | $1.53 |
Mar 5/24 | Mar 1/24 | Klima Thomas J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 199,000 | |
Mar 5/24 | Mar 4/24 | Klima Thomas J | Direct Ownership | Common Stock | S - Open market or private sale | -4,573 | $1.53 |
Feb 6/24 | Feb 5/24 | Klima Thomas J | Direct Ownership | Common Stock | S - Open market or private sale | -2,714 | $0.903 |
Feb 6/24 | Feb 5/24 | Vittiglio Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -5,217 | $0.903 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |